Health Care [ 9/12 ] | Biotechnology [ 65/74 ]
NASDAQ | Common Stock
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.
Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer.
The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers.
It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer.
BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 17, 25 | -2.33 Decreased by -228.17% | -1.94 Decreased by -20.10% |
| Dec 12, 24 | -0.22 Increased by +56.00% | -0.30 Increased by +26.67% |
| Oct 23, 24 | -0.07 Increased by +53.33% | -0.46 Increased by +84.78% |
| Jun 14, 24 | 0.11 Increased by +114.29% | -0.55 Increased by +120.00% |
| Mar 18, 24 | -0.71 Decreased by -914.29% | -0.20 Decreased by -255.00% |
| Dec 14, 23 | -0.50 Increased by +50.98% | -0.18 Decreased by -177.78% |
| Oct 25, 23 | -0.15 Increased by +53.13% | -0.39 Increased by +61.54% |
| Mar 15, 23 | -0.77 Decreased by -220.83% | -0.35 Decreased by -120.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jan 31, 25 | 0.00 Decreased by N/A% | -6.29 M Increased by +44.30% | Decreased by N/A% Decreased by N/A% |
| Oct 31, 24 | 0.00 Decreased by N/A% | -5.80 M Decreased by -196.68% | Decreased by N/A% Decreased by N/A% |
| Jul 31, 24 | 22.67 K Increased by +N/A% | -1.21 M Increased by +49.80% | Decreased by -5.36 K% Decreased by N/A% |
| Apr 30, 24 | 0.00 Decreased by N/A% | 1.72 M Increased by +139.29% | Increased by +N/A% Decreased by N/A% |
| Jan 31, 24 | 0.00 Decreased by N/A% | -11.29 M Increased by +58.03% | Decreased by N/A% Decreased by N/A% |
| Oct 31, 23 | 0.00 Decreased by N/A% | 6.00 M Increased by +88.13% | Increased by +N/A% Decreased by N/A% |
| Jul 31, 23 | 0.00 Decreased by N/A% | -2.42 M Increased by +91.67% | Decreased by N/A% Decreased by N/A% |
| Apr 30, 23 | 0.00 Decreased by N/A% | -4.37 M Decreased by -289.70% | Decreased by N/A% Decreased by N/A% |